Reproductive Hormones and Gonadal Axes
Why does a woman ovulate roughly once every 28 days? A man makes sperm continuously from puberty to old age. Both patterns emerge from the same three-tier hormonal circuit. It is wired slightly differently in each case. This circuit — the hypothalamic-pituitary-gonadal (HPG) axis — is the master control system for reproduction in all vertebrates. It decides when puberty begins, whether an egg is released, and how much testosterone circulates. It also explains why fertility fails when any link in the chain breaks. The HPG axis matters far beyond reproduction itself. Its steroid outputs — estrogen, progesterone, testosterone — shape bone density, muscle mass, and brain development. They also affect cardiovascular risk and behavior across the lifespan. Understanding this axis explains why hormonal contraceptives work. It explains why anabolic steroid abuse shuts down natural testosterone production. It explains why certain tumors cause precocious puberty. It also explains why menopause triggers predictable cascades of physiological change. It is also a textbook case of a control system that can run in two fundamentally different modes. Males show steady tonic feedback; females show a self-reversing cyclic feedback. Both arise from nearly identical molecular parts. The big picture is this: a hypothalamic pulse generator drives pituitary gonadotropins. These gonadotropins drive gonadal steroids, which feed back to close the loop. The elegance lies in the details. Pulse frequency codes information. The sign of estrogen's feedback flips from negative to positive at a critical threshold. This flip produces the LH surge that triggers ovulation. This is one of the few endocrine circuits where negative feedback is deliberately overridden by the system's own design. This article builds the axis component by component. It walks through the classic experiments that revealed pulsatile GnRH secretion and the estrogen-driven LH surge. It then applies the logic to worked clinical and physiological problems. It builds on The Hypothalamus-Pituitary Axis and Feedback Control in Endocrine Systems. It also sets up later integration with other neuroendocrine loops in Integration of Hormonal Control.
- The HPG axis runs hypothalamus (GnRH) → anterior pituitary (LH, FSH) → gonads (testosterone, estrogen, progesterone, inhibin) → feedback to both upper levels.
- GnRH is secreted in discrete pulses (roughly every 60–120 min); pulse frequency and amplitude, not steady concentration, encode the signal that pituitary gonadotropes decode.
- In males, testosterone and inhibin exert continuous (tonic) negative feedback, producing a stable, non-cyclic hormonal steady state.
- In females, low-to-moderate estrogen suppresses LH/FSH (negative feedback), but sustained high estrogen from a mature follicle flips to positive feedback, triggering the mid-cycle LH surge and ovulation.
- Knobil's isolated-hypothalamus monkey experiments and pulsatile GnRH pump studies proved that pulse pattern, not just hormone level, is the control variable — a principle now exploited clinically (pulsatile GnRH restores fertility; continuous GnRH agonists suppress it).
- Disruptions at any level — hypothalamic (stress, energy deficit), pituitary (tumors), or gonadal (menopause, gonadal dysgenesis) — produce distinct, diagnostically useful hormone signatures.
The HPG axis is a single three-level pulsatile feedback circuit that runs as a stable tonic loop in males and as a self-reversing cyclic loop in females, because estrogen's feedback sign flips from negative to positive once a threshold concentration is sustained long enough.
The core idea
The hypothalamic-pituitary-gonadal (HPG) axis is the neuroendocrine circuit governing reproduction. It has three anatomical tiers. The hypothalamus (arcuate nucleus and preoptic area) secretes gonadotropin-releasing hormone (GnRH), a decapeptide, into the hypophyseal portal blood. GnRH travels a short distance to the anterior pituitary, where it binds receptors on gonadotrope cells, stimulating synthesis and pulsatile release of two glycoprotein gonadotropins: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These circulate systemically to the gonads — testes or ovaries — where they drive gametogenesis and steroidogenesis. The gonads in turn secrete testosterone (testes), estradiol and progesterone (ovaries), and inhibin (both), which travel back in the blood to modulate hypothalamic and pituitary output. This closes the loop: hypothalamus → pituitary → gonad → back to hypothalamus and pituitary. Two distinct feedback regimes coexist within the same wiring diagram, distinguished by pattern rather than architecture. Tonic feedback is the default: a gonadal steroid (testosterone in men, basal estradiol/progesterone in women) continuously restrains GnRH/LH/FSH release, holding hormone levels in a narrow steady band — analogous to a thermostat. Cyclic feedback, unique to the ovarian axis, alternates between negative feedback (low-moderate estradiol, most of the menstrual cycle) and a switch to positive feedback when estradiol from a dominant follicle exceeds roughly 200 pg/mL and remains elevated for about 36–50 hours. This sustained high estradiol paradoxically stimulates GnRH pulse frequency and pituitary LH sensitivity, producing the massive LH surge that triggers ovulation. No such positive-feedback switch operates in the male axis, which explains why sperm production is continuous while egg release is episodic. A crucial, often-missed refinement is that GnRH is not secreted as a smooth trickle — it comes in discrete pulses, and the frequency of those pulses is itself an information-carrying signal decoded differently by gonadotrope cells to preferentially favor LH or FSH synthesis. This pulsatility is not a biological quirk; it is functionally essential, since continuous, non-pulsatile GnRH exposure paradoxically shuts the whole axis down by desensitizing pituitary GnRH receptors — a phenomenon exploited therapeutically.
Mechanism
Step 1 — The pulse generator. Neurons of the arcuate nucleus (hypothalamus), often called the GnRH pulse generator and driven by upstream kisspeptin neurons, fire in synchronized bursts. Each burst releases a bolus of GnRH into the hypophyseal portal capillaries. In humans, pulse interval is roughly:
| Phase | Typical GnRH/LH pulse frequency |
|---|---|
| Early follicular phase | ~1 pulse per 90–120 min |
| Late follicular phase | ~1 pulse per 60–70 min |
| Luteal phase | ~1 pulse per 3–8 hours (slowed, higher amplitude) |
| Adult male (tonic) | ~1 pulse per 90–120 min, stable |
Step 2 — Pituitary decoding. Gonadotrope cells express GnRH receptors (a Gq-coupled GPCR) that trigger phospholipase C → IP₃/DAG → Ca²⁺ release → LH and FSH exocytosis and new synthesis. High-frequency pulses preferentially favor LH-β subunit transcription; slower, lower-frequency pulses favor FSH-β. This frequency-decoding is a key reason the same GnRH molecule produces different LH:FSH ratios across the cycle.
Step 3 — Gonadal steroidogenesis. In the ovary, the two-cell, two-gonadotropin model governs estrogen synthesis: LH acts on theca cells, inducing cholesterol side-chain cleavage and 17α-hydroxylase activity to make androgens (androstenedione); these diffuse to adjacent granulosa cells, where FSH-induced aromatase converts them to estradiol. In the testis, LH stimulates Leydig cells to produce testosterone via the same steroidogenic cascade; FSH acts on Sertoli cells to support spermatogenesis and stimulate inhibin B secretion.
Step 4 — Feedback. Testosterone (directly, and via aromatization to estradiol in the hypothalamus) suppresses GnRH pulse frequency and pituitary LH sensitivity — classic negative feedback, tonic and continuous. Inhibin B from Sertoli/granulosa cells selectively suppresses pituitary FSH. In the ovary, low-moderate estradiol plus progesterone (luteal phase) suppress GnRH/LH — negative feedback — but a sustained estradiol level above ~200 pg/mL for 1.5–2 days switches hypothalamic kisspeptin neurons (in a distinct anteroventral periventricular subpopulation) into a stimulatory mode, sharply increasing GnRH pulse frequency and pituitary LH responsiveness. This produces the LH surge, which triggers final oocyte maturation, follicle rupture, and ovulation roughly 10–12 hours after the LH peak.
The menstrual cycle as a feedback trajectory. Across roughly 28 days, follicular-phase estradiol rises slowly (negative feedback keeps LH/FSH low and stable), then accelerates as the dominant follicle matures. Once estradiol exceeds the threshold and stays high for the required duration, feedback flips to positive: LH surges roughly 6- to 10-fold within 24–36 hours, triggering ovulation. The resulting corpus luteum then secretes progesterone (plus estradiol), restoring negative feedback and holding LH/FSH low through the luteal phase; if fertilization does not occur, the corpus luteum regresses, steroid levels fall, and the resulting drop in negative feedback allows FSH to rise again, recruiting the next cohort of follicles.
The evidence
Ernst Knobil's isolated hypothalamus experiments (1970s–1980s, rhesus monkeys). Knobil's group at the University of Texas surgically lesioned the arcuate nucleus in female rhesus monkeys, abolishing endogenous GnRH secretion and collapsing LH/FSH to near zero — direct proof that the arcuate hypothalamus is the obligatory pacemaker for gonadotropin release. Critically, they then restored normal ovulatory cycles by infusing synthetic GnRH via a programmable pump delivering one pulse per hour, exactly mimicking the endogenous rhythm. When they instead gave the same total dose of GnRH as a continuous, non-pulsatile infusion, gonadotropin secretion failed to recover — LH and FSH stayed low despite constant hormone exposure. This was the decisive proof that pulse pattern, not cumulative hormone concentration, is the signal the pituitary reads. Varying the pump to deliver pulses every 3 hours versus every 1 hour altered the LH:FSH ratio, demonstrating frequency-dependent decoding — the physiological basis for later use of GnRH agonists (given continuously to desensitize the axis, e.g., in prostate cancer or precocious puberty) versus pulsatile GnRH (given rhythmically to restore fertility in hypothalamic hypogonadism).
Discovery of the LH surge mechanism — estrogen positive feedback (1970s human and animal studies). Early clinical observations noted that a single large injection of estrogen in women with hypothalamic amenorrhea, timed appropriately, could trigger an LH surge rather than suppress LH — the opposite of the expected negative feedback. Controlled studies (Yen and colleagues, and parallel work in rhesus monkeys and rodents) established that the duration and magnitude of estrogen exposure determines the sign of feedback: brief or low-dose estrogen suppresses LH, while sustained high-dose estrogen (mimicking a mature preovulatory follicle) for at least ~36 hours reliably provokes a surge. Measuring plasma estradiol and LH together across natural menstrual cycles confirmed the temporal sequence predicted by the model: estradiol peaks approximately one day before the LH surge, and progesterone from the newly forming corpus luteum rises only after the LH peak — establishing the causal order estradiol rise → LH surge → ovulation → progesterone rise.
Kallmann syndrome as a natural experiment. Patients with Kallmann syndrome fail to make GnRH because GnRH neurons fail to migrate from the olfactory placode to the hypothalamus during development (often with anosmia, since the same migratory pathway carries olfactory neurons). These patients have low LH/FSH and low sex steroids (hypogonadotropic hypogonadism) that is fully correctable by exogenous pulsatile GnRH administration — but not by continuous GnRH — providing a clean, clinically observed confirmation of Knobil's pulsatility principle in humans.
Worked examples
Example 1 — Reading a hormone panel to localize a lesion. A 24-year-old woman has secondary amenorrhea (no periods for 8 months). Labs show:
| Hormone | Patient value | Normal range (follicular phase) |
|---|---|---|
| FSH | 1.2 mIU/mL | 3–10 mIU/mL |
| LH | 0.8 mIU/mL | 2–12 mIU/mL |
| Estradiol | 15 pg/mL | 30–100 pg/mL |
| Prolactin | 9 ng/mL | 5–25 ng/mL (normal) |
Reasoning: both gonadotropins are low, not elevated, alongside low estradiol. If the problem were ovarian (e.g., primary ovarian insufficiency), loss of negative feedback from a failing ovary would make FSH/LH rise (hypergonadotropic hypogonadism). Instead we see low estradiol with low LH/FSH — the ovaries are receiving too little stimulation, not failing intrinsically. This pattern localizes the defect to the hypothalamus or pituitary (hypogonadotropic hypogonadism). Given normal prolactin (ruling out a prolactinoma suppressing GnRH) and a history of amenorrhea following a period of intense exercise and caloric restriction, the most likely diagnosis is functional hypothalamic amenorrhea: energy deficit suppresses hypothalamic kisspeptin/GnRH pulse frequency, collapsing the entire axis from the top down. Treatment logic follows directly from Knobil's principle: restoring body weight/energy balance, or administering pulsatile GnRH via pump (one pulse every ~90 minutes), restores cyclic ovulation — whereas continuous GnRH agonist would do the opposite.
Example 2 — Predicting the effect of exogenous testosterone on fertility. A 30-year-old male bodybuilder self-administers high-dose testosterone for 6 months. Before assuming this "boosts" his reproductive system, apply the tonic-feedback logic: exogenous testosterone circulates systemically and is detected by the hypothalamus and pituitary exactly like endogenous testosterone. Predict: 1. Serum testosterone: markedly elevated (exogenous source). 2. Hypothalamic GnRH pulse frequency: suppressed, because high testosterone (and its aromatized estradiol) delivers strong negative feedback. 3. Pituitary LH: suppressed — with no LH, endogenous Leydig cell testosterone production collapses, and intratesticular testosterone (normally ~100x higher than serum levels and essential for spermatogenesis) falls sharply. 4. Pituitary FSH: suppressed, and with it Sertoli cell support for spermatogenesis. 5. Net effect on sperm count: falls, often to azoospermia, despite — indeed because of — sky-high serum testosterone. This example demonstrates why exogenous androgens are a leading reversible cause of male infertility, and it directly illustrates tonic negative feedback: the axis cannot distinguish "enough testosterone" that came from the testis versus from an injection — it only reads the circulating steroid concentration.
Common misconceptions & traps
| Misconception | Correction |
|---|---|
| "Estrogen always suppresses LH/FSH (only negative feedback exists)" | Sustained high estradiol from a mature follicle switches feedback to positive, producing the LH surge — the sign of feedback depends on estradiol's level and duration. |
| "GnRH works like a simple hormone — more GnRH means more LH" | Continuous, non-pulsatile GnRH shuts down the pituitary response via receptor desensitization; only pulsatile delivery sustains LH/FSH secretion. |
| "Testosterone injections improve fertility" | Exogenous testosterone suppresses endogenous LH/FSH, collapsing intratesticular testosterone and often causing infertility despite high serum levels. |
| "High FSH/LH means a healthy, active reproductive axis" | High gonadotropins with low sex steroids indicates gonadal failure (loss of negative feedback), e.g., menopause or primary ovarian insufficiency — not axis health. |
| "Inhibin and estradiol do the same job" | Inhibin selectively suppresses FSH; estradiol/progesterone/testosterone act on both LH and FSH — the two feedback signals are not redundant. |
| "The menstrual cycle is driven only by the ovary" | The ovary and the hypothalamic-pituitary units co-regulate each other bidirectionally; the cycle is a property of the whole loop, not the ovary alone. |
The scientist behind it
Origins · 1 minErnst Knobil and how this was discovered
Knobil was a physiologist who built one of the most sophisticated primate neuroendocrine research programs of the 20th century, using chronically instrumented rhesus monkeys with lesioned hypothalami and programmable GnRH infusion pumps to dissect the control logic of the reproductive axis with a rigor rarely achieved in human endocrinology.
Knobil trained as a physiologist and spent much of his career asking a deceptively simple question: what, exactly, does the hypothalamus need to do — not just secrete, but do in what pattern — to keep the pituitary-gonadal axis running. Rather than relying on correlational hormone measurements in intact animals, he built a reduction: monkeys whose arcuate nucleus was destroyed, whose GnRH secretion was replaced entirely by an external, programmable pump. This let him treat pulse frequency as an independent variable he could dial up, down, or eliminate — and observe the pituitary's response directly. The result was a mechanistic, causal demonstration (not just correlation) that pulsatility itself is the signal, a finding that reshaped both basic neuroendocrinology and clinical practice — from pulsatile GnRH fertility therapy to continuous GnRH-agonist chemical castration in prostate cancer.
Origins · 1 minhow this was discovered
Where this matters today
Assisted reproduction and infertility treatment. Pulsatile GnRH pumps and gonadotropin injections (recombinant FSH/LH) are used to induce ovulation in women with hypothalamic amenorrhea or polycystic ovary syndrome, and to stimulate multi-follicular development for in vitro fertilization, directly applying the frequency-decoding principle Knobil established.
Hormonal contraception. Combined oral contraceptives supply continuous low-dose estrogen and progestin, holding the axis in sustained negative feedback so estradiol never reaches the surge threshold — ovulation is prevented not by blocking the ovary directly but by silencing the LH surge at its hypothalamic-pituitary source.
Prostate and breast cancer therapy. Continuous GnRH agonists (leuprolide, goserelin) initially stimulate then profoundly desensitize pituitary gonadotropes, crashing testosterone or estrogen to castrate levels — "medical castration" — used to slow hormone-sensitive cancers without surgery.
Precocious and delayed puberty. Measuring baseline and GnRH-stimulated LH/FSH distinguishes central (hypothalamic-pituitary) precocious puberty, treatable with continuous GnRH agonists, from peripheral causes (e.g., an estrogen- or androgen-secreting tumor) that bypass the axis entirely and are unresponsive to GnRH agonist therapy.
Menopause and andropause management. The rise in FSH/LH seen at menopause (loss of ovarian estradiol and inhibin removes negative feedback) is used diagnostically, and hormone replacement strategies are designed with the tonic-versus-cyclic feedback logic explicitly in mind to avoid unwanted endometrial stimulation.
Anabolic steroid abuse and testosterone replacement therapy. Clinicians now routinely counsel that exogenous testosterone suppresses spermatogenesis via the same tonic-feedback mechanism explored above, and co-administer agents like hCG (an LH mimetic) or SERMs to preserve intratesticular testosterone and fertility.
Ask the tutor: How would blocking aromatase (e.g., with an aromatase inhibitor) change LH, FSH, and testosterone levels in a man, and why?
Why is GnRH secreted in pulses instead of continuously?
Pulsatility is the actual signal the pituitary reads, not a side effect. Gonadotrope GnRH receptors desensitize under constant occupancy — continuous exposure causes receptor internalization and a collapse in LH/FSH output, as Knobil's monkey experiments showed directly. Discrete pulses, separated by a recovery interval, allow receptors to resensitize between bursts, sustaining responsiveness. Pulse frequency also carries information: faster pulses favor LH-β transcription, slower pulses favor FSH-β, letting one releasing hormone produce different gonadotropin ratios across the menstrual cycle. This is why clinical use exploits both regimes — pulsatile pumps to restore fertility, continuous agonists to suppress it.
What is the difference between tonic and cyclic feedback in the HPG axis?
Tonic feedback is a steady-state negative loop: a gonadal steroid (testosterone in men) continuously restrains GnRH/LH/FSH, holding hormone levels roughly constant day to day, similar to a thermostat. Cyclic feedback, seen in the ovarian axis, alternates between negative feedback for most of the cycle and a temporary switch to positive feedback when estradiol from a maturing follicle stays elevated long enough. That positive-feedback window produces the LH surge and ovulation, after which negative feedback (now progesterone-dominated) resumes. The male axis never undergoes this switch, which is why testosterone and sperm production remain relatively constant rather than cyclic.
How does the two-cell, two-gonadotropin model explain estrogen synthesis in the ovary?
Theca cells and granulosa cells divide the labor of estradiol synthesis. LH stimulates theca cells to convert cholesterol into androgens (mainly androstenedione) via steroidogenic enzymes including 17α-hydroxylase. These androgens diffuse across the basement membrane into adjacent granulosa cells, which express aromatase, an FSH-induced enzyme that converts androgens into estradiol. Neither cell type alone can complete the pathway efficiently — theca cells lack aromatase, and granulosa cells (before an LH-driven precursor supply) lack sufficient androgen substrate. This division of labor is why both LH and FSH, acting on two distinct cell types, are jointly required for normal estradiol production.
Why does menopause cause FSH and LH to rise sharply?
As ovarian follicles are depleted with age, the ovary produces progressively less estradiol and inhibin. Both hormones normally exert negative feedback on the hypothalamus and pituitary. As their levels fall, that restraint is lost, and the hypothalamic-pituitary unit responds with markedly increased GnRH pulsing and gonadotropin secretion — FSH often rises earlier and higher than LH because it is also under strong selective inhibin control. A persistently elevated FSH (typically well above 25–30 mIU/mL) is therefore a hallmark diagnostic sign of ovarian failure or menopause, reflecting loss of gonadal feedback rather than any pituitary abnormality.
How do combined oral contraceptives prevent ovulation using this axis?
Combined pills supply a steady low dose of synthetic estrogen and progestin every day. Because these steroids are held at a continuous, moderate level rather than allowed to rise sharply as a natural dominant follicle would, the hypothalamic-pituitary unit stays locked in the negative-feedback mode throughout the cycle. GnRH pulse frequency and LH/FSH secretion remain suppressed, no dominant follicle fully matures, and — crucially — estradiol never reaches the sustained high threshold required to flip feedback positive. Without that switch, no LH surge occurs, so ovulation is prevented even though the ovaries themselves are structurally normal.
What hormone pattern distinguishes hypothalamic/pituitary infertility from ovarian infertility?
Measuring LH and FSH alongside estradiol localizes the problem. If estradiol is low and LH/FSH are also low or inappropriately normal, the defect lies upstream — hypothalamic (e.g., functional hypothalamic amenorrhea, Kallmann syndrome) or pituitary (e.g., tumor, Sheehan syndrome) — because a healthy pituitary should be secreting high gonadotropins in response to low estradiol's reduced feedback. If estradiol is low and LH/FSH are markedly elevated, the ovary itself has failed (primary ovarian insufficiency or menopause), since the hypothalamus and pituitary are working correctly but the gonad cannot respond.
Does the same pulsatile GnRH logic apply to males?
Yes — the pulse generator, receptor decoding, and tonic negative feedback loop are essentially the same machinery, just without the estrogen-driven positive-feedback switch. Men show steady GnRH pulses roughly every 90–120 minutes throughout adulthood, driving fairly constant LH-stimulated testosterone production and FSH-supported spermatogenesis, rather than a monthly surge-and-release cycle. This is why men with hypothalamic hypogonadotropic hypogonadism (e.g., Kallmann syndrome) are also successfully treated with pulsatile GnRH pumps or gonadotropin injections to restore testosterone production and fertility, mirroring the female treatment logic but without needing to reproduce a surge.